NCT01785316View on ClinicalTrials.gov

The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases

PHASE3CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

June 15, 2013

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2023

Conditions
MelanomaUveal Neoplasms
Interventions
PROCEDURE

IHP

Trial Locations (1)

413 45

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

collaborator

University Hospital, Linkoeping

OTHER

collaborator

Uppsala University Hospital

OTHER

collaborator

Skane University Hospital

OTHER

collaborator

University Hospital, Umeå

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Vastra Gotaland Region

OTHER_GOV

NCT01785316 - The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases | Biotech Hunter | Biotech Hunter